FIELD: biotechnologies.
SUBSTANCE: method is described to stimulate expansion of haematopoietic stem cells (HSC) in vitro or in vivo. A population of cells is incubated, which contains HSC, in presence of at least one HSC modulator, at the same time the HSC modulator is selected from the group that consists of PGE2, PGI2, linoleic acid, 13(s)- HODE, L Y 171883, MIDA acid, eicosatrienoic acid, epoxyeicosatrienoic acid, ONO-259, Cay 1039, an agonist of receptor PGE2, 16,16-dimethyl-PCE2, 19(R)-hydroxy-PCE2, n-(n-acetamide benzamide)phenyl esther 16,16-dimethyl-PCE2, 11-desoxy-16,16-dimethyl-PCE2, 9-desoxy-9-methylene-16,16-dimethyl-PCE2, 9-desoxy-9-methylene-POE2, butaprost, sulprostone, serynolamide PGE2, methyl ester PGE2, 16-phenyltetranor-POE2, 15(S)-15-MeTnn-PGE2 and 15(R)-15-MeTnn-PGE2. A method is proposed to strength HSC acceptance, and also a method to strengthen recovery of haematopoietic stem cells, which include HSC incubation in presence of at least one HSC modulator.
EFFECT: invention expands arsenal of methods for stimulation of growth of haematopoietic stem cells in a subject.
28 cl, 24 dwg, 11 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF HEAMATOPOIETIC STEM CELL GROWTH MODULATION | 2007 |
|
RU2425876C2 |
METHOD FOR TISSUE REGENERATION STIMULATION | 2007 |
|
RU2480213C2 |
COMPOSITIONS INCREASING THE NUMBER OF COPIES OF THE VECTOR (VCN), AND METHODS OF USING | 2017 |
|
RU2744603C2 |
METHODS FOR GENE MODIFICATION OF HEMATOPOIETIC CELLS | 2019 |
|
RU2824194C2 |
METHOD OF CELL EXPANSION, METHOD OF OBTAINING CONDITIONED MEDIUM, POPULATION OF ADHESIVE MESENCHYMAL STROMAL CELLS OF PLACENTA OR ADIPOSE TISSUE, PHARMACEUTICAL COMPOSITION AND APPLICATION OF ADHESIVE MESENCHYMAL STROMAL CELLS OF PLACENTA OR ADIPOSE TISSUE IN TRANSPLANTATION | 2007 |
|
RU2433177C2 |
REPROGRAMMING HUMAN ENDOTHELIUM IN HEMATOPOIETIC PRECURSORS OF MULTIPLE LINES OF DIFFERENTIATION USING CERTAIN FACTORS | 2014 |
|
RU2691062C2 |
CULTURE MEDIUM FOR STEM CELLS | 2012 |
|
RU2714256C2 |
GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHOD FOR THEIR APPLICATION | 2013 |
|
RU2642319C2 |
METHOD OF TREATING RETINOPATHY IN PREMATURITY AND RELATED RETINOPATHIC DISEASES | 2006 |
|
RU2403906C2 |
IMMUNOLOGICALLY DISTINCT CELL SURFACE VARIANTS FOR CELL THERAPY APPLICATIONS | 2017 |
|
RU2793803C2 |
Authors
Dates
2013-09-20—Published
2007-03-26—Filed